Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomised, Placebo-Controlled Phase III Trial

被引：1
|
作者：
Pouliot, Frederic [1 ]
Pantuck, Allan J. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
来源：
EUROPEAN UROLOGY | 2009年 / 55卷 / 06期
关键词：
D O I：
10.1016/j.eururo.2009.03.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1482 / 1484
页数：3
相关论文
共 50 条
  • [41] Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
    Tepper, Stewart
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Daniel
    Lenz, Robert
    LANCET NEUROLOGY, 2017, 16 (06): : 425 - 434
  • [42] Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
    Sun, Hong
    Dodick, David W.
    Silberstein, Stephen
    Goadsby, Peter J.
    Reuter, Uwe
    Ashina, Messoud
    Saper, Joel
    Cady, Roger
    Chon, Yun
    Dietrich, Julie
    Lenz, Robert
    LANCET NEUROLOGY, 2016, 15 (04): : 382 - 390
  • [43] Cabergoline in advanced RLS: A double-blind, placebo-controlled, multicenter trial
    Stiasny-Kolster, K
    Ueberall, M
    Oertel, W
    MOVEMENT DISORDERS, 2002, 17 : S231 - S231
  • [44] Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-Blind, Placebo-Controlled Trial
    Parsons, J. Kellogg
    EUROPEAN UROLOGY, 2013, 64 (01) : 167 - 167
  • [45] Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial
    Tombal, Bertrand
    Lecouvet, Frederic
    EUROPEAN UROLOGY, 2012, 61 (06) : 1265 - 1266
  • [46] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [47] A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch
    Murphy, M
    Reaich, D
    Pai, P
    Finn, P
    Carmichael, AJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 314 - 317
  • [48] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    McCarey, DW
    McInnes, LB
    Madhok, R
    Hampson, R
    Scherbakova, O
    Ford, I
    Capell, HA
    Sattar, N
    LANCET, 2004, 363 (9426): : 2015 - 2021
  • [49] RENAVIV: A randomized phase III, double-blind, placebo-controlled study of pazopanib with or without abexinostat in patients with locally advanced or metastatic renal cell carcinoma.
    Aggarwal, Rahul Raj
    Thomas, Scott
    Hauke, Ralph J.
    Nordquist, Luke T.
    Munster, Pamela N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [50] Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial
    Bishop, Nick
    Adami, Silvano
    Ahmed, S. Faisal
    Anton, Jordi
    Arundel, Paul
    Burren, Christine P.
    Devogelaer, Jean-Pierre
    Hangartner, Thomas
    Eva Hosszu
    Lane, Joseph M.
    Lorenc, Roman
    Makitie, Outi
    Munns, Craig F.
    Paredes, Ana
    Pavlov, Helene
    Plotkin, Horacio
    Raggio, Cathleen L.
    Loreto Reyes, Maria
    Schoenau, Eckhard
    Semler, Oliver
    Sillence, David O.
    Steiner, Robert D.
    LANCET, 2013, 382 (9902): : 1424 - 1432
12345